E
Enrico Frigoli
Researcher at University of Bern
Publications - 43
Citations - 2451
Enrico Frigoli is an academic researcher from University of Bern. The author has contributed to research in topics: Acute coronary syndrome & Percutaneous coronary intervention. The author has an hindex of 15, co-authored 34 publications receiving 1813 citations. Previous affiliations of Enrico Frigoli include Vita-Salute San Raffaele University & University of Amsterdam.
Papers
More filters
Journal ArticleDOI
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Marco Valgimigli,Andrea Gagnor,Paolo Calabrò,Enrico Frigoli,Sergio Leonardi,Tiziana Zaro,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Alessandra Repetto,Ugo Limbruno,Bernardo Cortese,Paolo Sganzerla,Alessandro Lupi,Mario Galli,Salvatore Colangelo,Salvatore Ierna,Arturo Ausiello,Patrizia Presbitero,Gennaro Sardella,Ferdinando Varbella,Giovanni Esposito,Andrea Santarelli,Simone Tresoldi,Marco Stefano Nazzaro,Antonio Zingarelli,Nicoletta De Cesare,Stefano Rigattieri,Paolo Tosi,Cataldo Palmieri,Salvatore Brugaletta,Sunil V. Rao,Dik Heg,Martina Rothenbühler,Pascal Vranckx,Peter Jüni +35 more
TL;DR: In patients with acute coronary syndrome undergoing invasive management, radial as compared with femoral access reduces net adverse clinical events, through a reduction in major bleeding and all-cause mortality.
Journal ArticleDOI
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
Marco Valgimigli,Enrico Frigoli,Sergio Leonardi,Martina Rothenbühler,Andrea Gagnor,Paolo Calabrò,Stefano Garducci,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Alessandra Repetto,Ugo Limbruno,Roberto Garbo,Paolo Sganzerla,Filippo Russo,Alessandro Lupi,Bernardo Cortese,Arturo Ausiello,Salvatore Ierna,Giovanni Esposito,Patrizia Presbitero,Andrea Santarelli,Gennaro Sardella,Ferdinando Varbella,Simone Tresoldi,Nicoletta De Cesare,Stefano Rigattieri,Antonio Zingarelli,Paolo Tosi,Arnoud W J van 't Hof,Giacomo Boccuzzi,Elmir Omerovic,Manel Sabaté,Dik Heg,Peter Jüni,Pascal Vranckx +35 more
TL;DR: In patients with an acute coronary syndrome, the rates of major adverse cardiovascular events and net adverse clinical events were not significantly lower with bivalirudin than with unfractionated heparin.
Journal ArticleDOI
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
Marco Valgimigli,Enrico Frigoli,Sergio Leonardi,Pascal Vranckx,Martina Rothenbühler,Matteo Tebaldi,Ferdinando Varbella,Paolo Calabrò,Stefano Garducci,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Maurizio Ferrario,Ugo Limbruno,Roberto Garbo,Paolo Sganzerla,Filippo Russo,Marco Stefano Nazzaro,Alessandro Lupi,Bernardo Cortese,Arturo Ausiello,Salvatore Ierna,Giovanni Esposito,Giuseppe Ferrante,Andrea Santarelli,Gennaro Sardella,Nicoletta De Cesare,Paolo Tosi,Arnoud W J van 't Hof,Elmir Omerovic,Salvatore Brugaletta,Stephan Windecker,Dik Heg,Peter Jüni,Gianluca Campo,Lucia Uguccioni,Corrado Tamburino,Patrizia Presbitero,Dennis Zavalloni-Parenti,Fabio Ferrari,Roberto Ceravolo,Fabio Tarantino,Giampaolo Pasquetto,Gavino Casu,Stefano Mameli,Maria Letizia Stochino,Pietro Mazzarotto,Alberto Cremonesi,Francesco Saia,Giovanni Saccone,Fabio Abate,Andrea Picchi,Roberto Violini,Salvatore Colangelo,Giacomo Boccuzzi,Vincenzo Guiducci,Carlo Vigna,Antonio Zingarelli,Andrea Gagnor,Tiziana Zaro,Simone Tresoldi,Pietro Vandoni,Marco Contarini,Armando Liso,Dellavalle A,Salvatore Curello,Fabio Mangiacapra,Rosario Evola,Cataldo Palmieri,Camillo Falcone,Francesco Liistro,Manuela Creaco,Antonio Colombo,Alaide Chieffo,Andrea Perkan,Stefano De Servi,Dionigi Fischetti,Stefano Rigattieri,Alessandro Sciahbasi,Edoardo Pucci,Enrico Romagnoli,Claudio Moretti,Luciano Moretti,Raffaele De Caterina,Marcello Caputo,Marco Zimmarino,Ezio Bramucci,Emilio Di Lorenzo,Maurizio Turturo,Roberto Bonmassari,Carlo Penzo,Bruno Loi,Ciro Mauro,Anna Sonia Petronio,Gabriele Gabrielli,Antonio Micari,Flavia Belloni,Francesco Amico,Marco Comeglio,Claudio Fresco,Isala Klinieken,Nicolas M. Van Mieghem,Roberto Diletti,Evelyn Regar,Manel Sabaté,José Francisco Díaz Fernández,Vicente Mainar,José M. de la Torre Hernández +107 more
TL;DR: The prespecified final 1-year outcomes of the MATRIX programme, designed to assess the comparative safety and effectiveness of radial versus femoral access and of bivalirudin versus unfractionated heparin with optional glycoprotein IIb/IIIa inhibitors in patients with the whole spectrum of acute coronary syndrome undergoing invasive management, are described.
Journal ArticleDOI
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
Marco Valgimigli,Enrico Frigoli,Dik Heg,Jan G.P. Tijssen,Peter Jüni,Pascal Vranckx,Yukio Ozaki,Marie-Claude Morice,Bernard Chevalier,Yoshinobu Onuma,Stephan Windecker,Pim. A. L. Tonino,Marco Roffi,Maciej Lesiak,Felix Mahfoud,Jozef Bartunek,David Hildick-Smith,Antonio Colombo,Goran Stankovic,Andrés Iñiguez,Carl H. Schultz,Ran Kornowski,Paul Jau Lueng Ong,Mirvat Alasnag,Alfredo E. Rodriguez,Aris Moschovitis,Peep Laanmets,Michael Donahue,Sergio Leonardi,Pieter C. Smits +29 more
TL;DR: In this paper, the appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear.
Journal ArticleDOI
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.
Giuseppe Andò,Bernardo Cortese,Filippo Russo,Martina Rothenbühler,Enrico Frigoli,Giuseppe Gargiulo,Carlo Briguori,Pascal Vranckx,Sergio Leonardi,Vincenzo Guiducci,Flavia Belloni,Fabio Ferrari,José M. de la Torre Hernández,Salvatore Curello,Francesco Liistro,Andrea Perkan,Stefano De Servi,Gavino Casu,Dellavalle A,Dionigi Fischetti,Antonio Micari,Bruno Loi,Fabio Mangiacapra,Nunzio Russo,Fabio Tarantino,Francesco Saia,Dik Heg,Stephan Windecker,Peter Jüni,Marco Valgimigli,Matrix Investigators +30 more
TL;DR: In ACS patients who underwent invasive management, RA was associated with a reduced risk of AKI compared with FA, and Stratified analyses suggested greater benefit with RA than FA in patients at greater risk for AKI.